Abstract
To improve the management of resistant hypertension, the French Society of Hypertension, an affiliate of the French Society of Cardiology, has published a set of eleven recommendations. The primary objective is to provide the most up-to-date information based on the strongest scientific rationale and that is easily applicable to daily clinical practice. Resistant hypertension is defined as uncontrolled blood pressure on office measurements and confirmed by out-of-office measurements despite a therapeutic strategy comprising appropriate lifestyle and dietary measures and the concurrent use of three antihypertensive agents including a thiazide diuretic, a renin-angiotensin system blocker (ARB or ACEI) and a calcium channel blocker, for at least 4 weeks, at optimal doses. Treatment compliance must be closely monitored, as must factors that are likely to affect treatment resistance (excessive dietary salt intake, alcohol, depression, drug interactions and vasopressor drugs). If the diagnosis of resistant hypertension is confirmed, the patient should be referred to a hypertension specialist to screen for potential target organ damage and secondary causes of hypertension. The recommended treatment regimen is a combination therapy com...Continue Reading
References
Nov 18, 2004·JAMA : the Journal of the American Medical Association·Peter M OkinUNKNOWN LIFE Study Investigators
Jan 19, 2005·Hypertension·Hans IbsenYing Wan
Apr 9, 2008·Hypertension·David A CalhounRobert M Carey
Apr 1, 2009·Lancet·Henry KrumMurray Esler
May 28, 2009·Hypertension·David A CalhounRobert D Glazer
Apr 23, 2010·Journal of the American Society of Hypertension : JASH·Isabelle MulazziJacques Amar
Aug 4, 2010·Clinical Therapeutics·Suzanne OparilReinilde Heyrman
Nov 26, 2010·Lancet·UNKNOWN Symplicity HTN-2 InvestigatorsMichael Böhm
Apr 1, 2011·European Journal of Preventive Cardiology·Hélène Godet-MardirossianChristine de Peretti
May 4, 2011·Hypertension·Jan VáclavíkMilos Táborsky
Oct 5, 2011·Hypertension·Rodrigo P PedrosaGeraldo Lorenzi-Filho
Feb 22, 2012·Journal of Hypertension·Lin MengRutai Hui
Apr 4, 2012·Journal of Hypertension·Roland E SchmiederCostas Tsioufis
Jun 26, 2012·Journal of Hypertension·Guillaume BobriePierre-François Plouin
Sep 15, 2012·Archives of Cardiovascular Diseases·Atul PathakUNKNOWN French Society of Radiology
Jan 23, 2013·Journal of Hypertension·Oliver JungStefan W Toennes
Jun 14, 2013·Annales de cardiologie et d'angéiologie·X GirerdJ-J Mourad
Jul 3, 2013·Journal of Hypertension·Giuseppe ManciaUNKNOWN Task Force Members
Aug 7, 2013·Hypertension·Brent M EganDavid A Calhoun
Aug 13, 2013·American Journal of Hypertension·Salim S HayekChandan M Devireddy
Sep 12, 2013·Journal of the American College of Cardiology·Markus P SchlaichMurray D Esler
Apr 1, 2014·The New England Journal of Medicine·Deepak L BhattUNKNOWN SYMPLICITY HTN-3 Investigators
Nov 18, 2014·European Heart Journal·David E KandzariGeorge L Bakris
Jan 30, 2015·Lancet·Michel AziziUNKNOWN Renal Denervation for Hypertension (DENERHTN) investigators
Citations
Oct 25, 2016·Hipertensión y riesgo vascular·J C PradoJ Segura
Jul 11, 2020·Journal of Hypertension·Nathália C Leite-SantosUNKNOWN for CHRONIDE
Jan 17, 2017·Current Hypertension Reports·James E SharmanStéphane Laurent
Sep 6, 2020·Journal of Hypertension·Nathália C Leite-SantosUNKNOWN for CHRONIDE
Aug 4, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Satoshi UmemuraNobuhito Hirawa
Jul 19, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Beáta KőrӧsiJános Nemcsik
Aug 8, 2019·Clinical Hypertension·Hae-Young LeeShung Chull Chae
Feb 6, 2020·Hypertension·Gilad JaffeVivek Bhalla